Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Doron Schneider, MD

Articles by Doron Schneider, MD

The Importance of Patient-Reported Outcomes in Type 2 Diabetes: Insight From the PIONEER Program With Oral Semaglutide

ByDoron Schneider, MD,Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP,Tanya Dougherty, PharmD, BCPS

December 11th 2020

Latest Updated Articles

The Importance of Patient-Reported Outcomes in Type 2 Diabetes: Insight From the PIONEER Program With Oral Semaglutide
December 11th 2020

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD

Nutrition in Pregnancy May Shape Metabolic Health After Delivery